Jerome Goldstein

Summary

Publications

  1. doi request reprint A sumatriptan iontophoretic transdermal system for the acute treatment of migraine
    Jerome Goldstein
    San Francisco Clinical Research Center, San Francisco, CA 94109, USA
    Headache 52:1402-10. 2012
  2. doi request reprint Migraine management. Focus on meeting patients' individual needs
    Jerome Goldstein
    San Francisco Clinical Research Center, San Francisco Headache Clinic, San Francisco, CA 94109, USA
    Postgrad Med 117:17-25. 2005
  3. ncbi request reprint Treatment of severe, disabling migraine attacks in an over-the-counter population of migraine sufferers: results from three randomized, placebo-controlled studies of the combination of acetaminophen, aspirin, and caffeine
    J Goldstein
    San Francisco Headache Clinic, CA, USA
    Cephalalgia 19:684-91. 1999
  4. ncbi request reprint Frovatriptan: a review
    Jerome Goldstein
    San Francisco Headache Clinic, 909 Hyde Street, Suite 322, San Francisco, CA 94109, USA
    Expert Opin Pharmacother 4:83-93. 2003
  5. ncbi request reprint Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial
    Jerome Goldstein
    San Francisco Headache Clinic, San Francisco Clinical Research Center, CA 94109, USA
    Headache 45:973-82. 2005
  6. ncbi request reprint Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study
    Jerome Goldstein
    San Francisco Headache Clinic, CA 94109, USA
    Headache 46:444-53. 2006
  7. doi request reprint Switching from donepezil tablets to rivastigmine transdermal patch in Alzheimer's disease
    Carl H Sadowsky
    Nova SE University, Fort Lauderdale, Florida, USA
    Am J Alzheimers Dis Other Demen 24:267-75. 2009
  8. ncbi request reprint Frovatriptan for the acute treatment of migraine: a dose-finding study
    Jerome Goldstein
    San Francisco Clinical Research Center, Calif, USA
    Headache 42:41-8. 2002
  9. ncbi request reprint Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan
    Jerome Goldstein
    San Francisco Headache Clinic, 909 Hyde Street, Suite 322, San Francisco, CA 94109, USA
    Headache 46:1142-50. 2006
  10. doi request reprint Twelve-month tolerability and efficacy study of NP101, the sumatriptan iontophoretic transdermal system
    Timothy R Smith
    St John s Mercy Health Care, St Louis, MO, USA
    Headache 52:612-24. 2012

Collaborators

  • R Michael Gallagher
  • Mark W Pierce
  • R B Lipton
  • Arthur H Elkind
  • Chunming Li
  • Roger Cady
  • Timothy R Smith
  • Richard Singer
  • Carl H Sadowsky
  • Dara Jamieson
  • Alan Rapoport
  • Neil Pugach
  • Stephen Silberstein
  • Gus Alva
  • Thomas Vidic
  • Stephen Brannan
  • Harvey Schwartz
  • Jeffrey Geohas
  • Keith Edwards
  • Bennett Machanic
  • Barbara Koumaras
  • Miguel Flores
  • James Sutton
  • Alan Dengiz
  • Sean Hurley
  • Patricio Reyes
  • Marvin Kalafer
  • Ralph Richter
  • Carl Sadowsky
  • Ram Shrivastava
  • Todd Swick
  • Mary Stedman
  • David Spangler
  • Mahan Chehrenama
  • Xiangyi Meng
  • Derek Loewy
  • William Maier
  • Joshua Shua-Haim
  • Douglas Scharre
  • Michael Sauter
  • Steve Sitar
  • Jaron Winston
  • Gary Gerard
  • Vinod Bhatnagar
  • Joel Ross
  • Arvind Jariwala
  • Alan Siegal
  • Jay Ellis
  • Jason T Olin
  • David Margolin
  • Ronald Brenner
  • Ashok Patel
  • Meenakshi Patel
  • Troy Anderson
  • Susan Steen
  • Bill Fulk
  • Beth Safirstein
  • Padmini Atri
  • Barbara Harris
  • Phillip Green
  • Terry Copeland
  • John Grubbs
  • Ruben Bravo
  • Scott Cooper
  • F Michael Cutrer
  • X Henry Hu
  • Jeffrey Dayno
  • Robert Ryan
  • Charlotte Keywood

Detail Information

Publications13

  1. doi request reprint A sumatriptan iontophoretic transdermal system for the acute treatment of migraine
    Jerome Goldstein
    San Francisco Clinical Research Center, San Francisco, CA 94109, USA
    Headache 52:1402-10. 2012
    ..This phase III randomized, double-blind, placebo-controlled trial evaluated the efficacy and tolerability of this system for the acute treatment of migraine...
  2. doi request reprint Migraine management. Focus on meeting patients' individual needs
    Jerome Goldstein
    San Francisco Clinical Research Center, San Francisco Headache Clinic, San Francisco, CA 94109, USA
    Postgrad Med 117:17-25. 2005
    ..Patients should be monitored frequently so that treatment response can be determined and therapy adjusted as appropriate...
  3. ncbi request reprint Treatment of severe, disabling migraine attacks in an over-the-counter population of migraine sufferers: results from three randomized, placebo-controlled studies of the combination of acetaminophen, aspirin, and caffeine
    J Goldstein
    San Francisco Headache Clinic, CA, USA
    Cephalalgia 19:684-91. 1999
    ..To examine the benefits of acetaminophen, aspirin, and caffeine (AAC) in the treatment of severe, disabling migraine attacks, in a population of migraine sufferers for whom over-the-counter (OTC) medications are appropriate...
  4. ncbi request reprint Frovatriptan: a review
    Jerome Goldstein
    San Francisco Headache Clinic, 909 Hyde Street, Suite 322, San Francisco, CA 94109, USA
    Expert Opin Pharmacother 4:83-93. 2003
    ..Frovatriptan may be particularly well suited to patients with migraine of long duration, those prone to recurrence and those troubled by "triptan-type" side effects...
  5. ncbi request reprint Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial
    Jerome Goldstein
    San Francisco Headache Clinic, San Francisco Clinical Research Center, CA 94109, USA
    Headache 45:973-82. 2005
    ..To address the need for a rigorous, direct comparison of prescription and over-the-counter (OTC) migraine drugs and to expand the database on early treatment of migraine...
  6. ncbi request reprint Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study
    Jerome Goldstein
    San Francisco Headache Clinic, CA 94109, USA
    Headache 46:444-53. 2006
    ..Compare the effectiveness of a combination analgesic containing acetaminophen, aspirin, and caffeine to that of ibuprofen in the treatment of migraine...
  7. doi request reprint Switching from donepezil tablets to rivastigmine transdermal patch in Alzheimer's disease
    Carl H Sadowsky
    Nova SE University, Fort Lauderdale, Florida, USA
    Am J Alzheimers Dis Other Demen 24:267-75. 2009
    ..Evaluate safety and tolerability of switching from donepezil to rivastigmine transdermal patch in patients with mild to moderate Alzheimer's disease...
  8. ncbi request reprint Frovatriptan for the acute treatment of migraine: a dose-finding study
    Jerome Goldstein
    San Francisco Clinical Research Center, Calif, USA
    Headache 42:41-8. 2002
    ..To determine the optimal dose and tolerability of frovatriptan in the acute treatment of migraine...
  9. ncbi request reprint Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan
    Jerome Goldstein
    San Francisco Headache Clinic, 909 Hyde Street, Suite 322, San Francisco, CA 94109, USA
    Headache 46:1142-50. 2006
    ....
  10. doi request reprint Twelve-month tolerability and efficacy study of NP101, the sumatriptan iontophoretic transdermal system
    Timothy R Smith
    St John s Mercy Health Care, St Louis, MO, USA
    Headache 52:612-24. 2012
    ..To assess the long-term tolerability and efficacy of NP101, a novel transdermal sumatriptan patch being developed for the acute treatment of migraine...
  11. ncbi request reprint Real-world experiences in migraine therapy with rizatriptan
    Dara Jamieson
    University of Pennsylvania, Philadelphia 19486, USA
    Headache 43:223-30. 2003
    ..To evaluate the effectiveness of rizatriptan for acute migraine treatment and patient satisfaction with the drug in usual clinical practice settings...
  12. ncbi request reprint Randomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate or severe
    Roger Cady
    Headache Care Center, Primary Care Network, Inc, Springfield, MO, USA
    Curr Med Res Opin 20:1465-72. 2004
    ..To evaluate whether frovatriptan would provide greater relief if given early during a migraine attack...
  13. ncbi request reprint Dose range-finding studies with frovatriptan in the acute treatment of migraine
    Alan Rapoport
    The New England Center for Headache, Stamford, Conn 06902 1251, USA
    Headache 42:S74-83. 2002
    ..To determine the optimum dose of frovatriptan for the acute treatment of migraine...